Disc Medicine Shares Rise 31.5% on Day of Positive Phase 3 Results

Your call?🐂 Bullish🐻 Bearish

31.5%

share price rise

The APOLLO trial met both primary endpoints in patients with two light-sensitive blood disorders. The Monday share price was an intraday observation, not a closing figure.